BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3612173)

  • 1. Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease.
    Rinne JO; Paljärvi L; Rinne UK
    J Neurol Sci; 1987 Jun; 79(1-2):67-76. PubMed ID: 3612173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease.
    Etienne P; Robitaille Y; Wood P; Gauthier S; Nair NP; Quirion R
    Neuroscience; 1986 Dec; 19(4):1279-91. PubMed ID: 3822122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ
    Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
    [No Abstract]   [Full Text] [Related]  

  • 4. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
    Arai H; Iizuka R
    Nihon Rinsho; 1988 Jul; 46(7):1491-5. PubMed ID: 3221455
    [No Abstract]   [Full Text] [Related]  

  • 5. The nucleus basalis of Meynert in neurological dementing disease: a review.
    Chozick B
    Int J Neurosci; 1987 Nov; 37(1-2):31-48. PubMed ID: 2960633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.
    Lippa CF; Smith TW; Perry E
    J Neural Transm (Vienna); 1999; 106(5-6):525-35. PubMed ID: 10443555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell loss and nuclear hypertrophy in topographical subdivisions of the nucleus basalis of Meynert in Alzheimer's disease.
    Iraizoz I; de Lacalle S; Gonzalo LM
    Neuroscience; 1991; 41(1):33-40. PubMed ID: 2057064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.
    Pearson RC; Sofroniew MV; Cuello AC; Powell TP; Eckenstein F; Esiri MM; Wilcock GK
    Brain Res; 1983 Dec; 289(1-2):375-9. PubMed ID: 6362777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease.
    Vogels OJ; Broere CA; ter Laak HJ; ten Donkelaar HJ; Nieuwenhuys R; Schulte BP
    Neurobiol Aging; 1990; 11(1):3-13. PubMed ID: 2183081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Morphometric study of the magnocellular basal forebrain system in patients with Alzheimer's disease].
    Kobayashi K; Fukutani Y; Nakamura I; Kawasaki Y; Suzuki M; Yamaguchi N; Nakanishi I
    No To Shinkei; 1990 Apr; 42(4):345-51. PubMed ID: 2390367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.
    Gilmor ML; Erickson JD; Varoqui H; Hersh LB; Bennett DA; Cochran EJ; Mufson EJ; Levey AI
    J Comp Neurol; 1999 Sep; 411(4):693-704. PubMed ID: 10421878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of choline acetyltransferase activity between the nucleus basalis of Meynert and the cerebral cortex.
    Koshimura K; Kato T; Yohyama I; Nakamura S; Kameyama M
    Neurosci Res; 1987 Apr; 4(4):330-6. PubMed ID: 3601249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlative decrease of large neurons in the neostriatum and basal nucleus of Meynert in Alzheimer's disease.
    Oyanagi K; Takahashi H; Wakabayashi K; Ikuta F
    Brain Res; 1989 Dec; 504(2):354-7. PubMed ID: 2598036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease.
    Salehi A; Verhaagen J; Dijkhuizen PA; Swaab DF
    Neuroscience; 1996 Nov; 75(2):373-87. PubMed ID: 8931004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B
    J Neurol Neurosurg Psychiatry; 1984 Feb; 47(2):201-3. PubMed ID: 6707659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunction of the brain cholinergic system during aging and after lesions of the nucleus basalis of Meynert.
    Pepeu G; Marconcini Pepeu I
    J Neural Transm Suppl; 1994; 44():189-94. PubMed ID: 7897390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ; Jaffar S; Levey AI
    J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic changes in the basal nucleus of Meynert and in the diagonal band nucleus in Alzheimer's disease--a quantitative Golgi investigation.
    Arendt T; Zvegintseva HG; Leontovich TA
    Neuroscience; 1986 Dec; 19(4):1265-78. PubMed ID: 3822121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic receptor plasticity in rats lesioned in the nucleus basalis of Meynert.
    Vige X; Briley M
    Neuropharmacology; 1989 Jul; 28(7):727-32. PubMed ID: 2761681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (Ch4) of Alzheimer's patients.
    Kordower JH; Gash DM; Bothwell M; Hersh L; Mufson EJ
    Neurobiol Aging; 1989; 10(1):67-74. PubMed ID: 2547171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.